From Johns Hopkins Bloomberg School of Public Health—Institute for Health and Productivity Studies (Dr Goetzel) and Truven Health Analytics (Drs Goetzel and Tabrizi), Bethesda, Md; Truven Health Analytics (Dr Henke), Cambridge, Mass; University of Arizona School of Medicine and University of California San Francisco School of Medicine (Dr Pelletier); US Preventive Medicine (Dr Loeppke), Jacksonville, Fla; American Psychological Association (Dr Ballard), Washington, DC; StayWell (Drs Grossmeier and Anderson), St Paul, Minn; The Vitality Institute (Dr Yach), New York, NY; The University of Alabama (Dr Kelly), Tuscaloosa; Mercer (Dr McCalister), Austin, Tex; Optum (Dr Serxner), San Francisco, Calif; Population Health Alliance (Dr Selecky), Washington, DC; Exxon Mobil Corporation (Dr Shallenberger), Houston, Tex; Stanford University School of Medicine (Dr Fries), Palo Alto, Calif; The Dow Chemical Company (Dr Baase), Midland, Mich; Johnson & Johnson (Dr Isaac), New Brunswick; Prudential Financial (Dr Crighton), Newark, NJ; USAA (Dr Wald), San Antonio, Tex; IBM Corporation (Ms Exum), Somers, NY; Cummins, Inc (Dr Shurney), Columbus, Ind; and American Specialty Health (Dr Metz), San Diego, Calif.
Address correspondence to: Ron Z. Goetzel, PhD, Institute for Health and Productivity Studies, Johns Hopkins Bloomberg School of Public Health, and Truven Health Analytics, 7700 Old Georgetown Rd, Ste 650, Bethesda, MD 20814 ([email protected]).
Funding for this study was provided by American Specialty Health.
The authors declare no conflicts of interest.
